Biggest News Aggregation in the World
📰 Johnson Phase News

Johnson Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnson Phase. Real-time updates on events, politics, business and more.

Johnson & Johnson Booster Adds to COVID-19 Protection - New Delhi Times - India Only International Newspaper

U.S. pharmaceutical company Johnson & Johnson announced Wednesday that clinical trials it has conducted show a second shot of the company’s COVID-19 vaccine produced an antibody response nine times higher than the original single dose. In a news release, the company said it conducted two Phase 1/2a studies in individuals previously vaccinated with its single-shot…
Mathai Mammen Us Centers For Disease European Medicines Agency Drug Administration Disease Control Johnson Phase

Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response

Share this article Share this article NEW BRUNSWICK, N.J., July 1, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced data that demonstrated its single-shot COVID-19 vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent SARS-CoV-2 viral variants. In addition, the data showed that the durability of the immune response lasted through at least eight months, the length of time evaluated to date. The two pr...
South Africa United States Paul Stoffels Dan Barouch Mathai Mammen Janssen Biotech Inc

COVID-19 vaccine FAQs: Efficacy, immunity to illness vs. infection (yes, they're different), new variants and the likelihood of eradication

As of March 8, four COVID-19 vaccines have been approved for emergency use in Canada. Two of them, the mRNA vaccines from Pfizer/BioNTech and Moderna vaccines, were approved for use in Canada in December 2020. The Oxford/AstraZeneca vaccine was approved on Feb. 26, followed by the Johnson & Johnson vaccine on March 5. A fifth vaccine was submitted on Jan. 29 by Novavax for approval in Canada. If approved, the vaccine would be produced in Canada. How effective these vaccines may be in ending t...
South Africa United States United Kingdom Oxford Astrazeneca Carlos Osorio Lars Hagberg

UK, UK HealthCare Reflect on a Year of COVID-19

of LEXINGTON, Ky. (March 4, 2021) — March marks one year since the COVID-19 global pandemic disrupted and altered everyone’s life. On March 6, it will be a year since Kentucky confirmed the first case of COVID-19 – a patient admitted to UK Chandler Hospital. A few days later, on March 11, the University of Kentucky announced it would transition its campus of more than 30,000 students to online instruction – initially just for two weeks following spring break -- but eventually from Mar...
Fayette County United States United Kingdom White House District Of Columbia Eastern State Hospital
Source: uky.edu

Covid-19: Over 17 000 healthcare workers vaccinated in Gauteng

News24/Alex Mitchley The Dr George Mukhari Academic Hospital is the latest site in Gauteng to administer the Covid-19 jab. Gauteng wants to vaccinate 8 520 healthcare workers this week.  The J&J Phase 3b Implementation Study has, so far, seen  17 994 healthcare workers receiving the jab. As the Dr George Mukhari Academic Hospital in Tshwane became the latest site in Gauteng to administer the Covid-19 jab, the province is looking to vaccinate 8 520 more healthcare workers this week. South Afr...
South Africa Chris Hani Baragwanath Richard Lebethe Joe Phaahla Deputy Khumbudzo Ntshavheni Leah Nkomo
Source: news24.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

New Data Boosts Confidence In J&J Vaccine

New data on early-stage trials of Johnson & Johnson’s Covid-19 vaccine are giving experts increased confidence that the vaccine will work as they await results of a large Phase 3 trial expected in the coming weeks. The trial data, published Wednesday by the New England Journal of Medicine, offered an expanded and updated account of a paper posted weeks ago on a so-called preprint server. The paper showed that 90% or more of participants developed neutralizing antibodies against the vi...
New York United States Moncef Slaoui Louise Chen Josh Nathan Kazis Jared Holz

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science